Skip to main content

Arrowhead Pharmaceuticals, Inc 10-K for FY2023

Arrowhead Pharmaceuticals, Inc. (ARWR)

10-K 2023-11-29 For: 2023-09-30
View Original
Added on April 08, 2026

About this 10-K

Arrowhead Pharmaceuticals, Inc filed this 10-K on November 29, 2023, covering the fiscal year ended September 30, 2023 (FY2023).

Headline figures

Fiscal year ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$240.74M
down 1.0% from $243.23M a year earlier
Net loss
$205.28M
compared with a net loss of $176.06M a year earlier
Diluted EPS
-$1.92
compared with -$1.67 a year earlier